ATLASTwist Bioscience (TWST) Q4 fiscal 2026 earnings results
Twist Bioscience (TWST) reported EPS of -$0.32 against an analyst estimate of -$0.20: a miss of $0.12 (60.0%). The quarter ended Sep 30, 2026; the company reported on Thursday, November 12, 2026, before the open.
Status: Confirmed · 14:37 ET, Nov 12 · Source: EODHD (calendar and fundamentals, cross-checked)
Get an email before and after Twist Bioscience reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountTWST Q4 fiscal 2026 results at a glance
| EPS reported | -$0.32 |
|---|---|
| EPS estimate | -$0.20 |
| Surprise | Miss · -$0.12 (-60.0%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Nov 12, 2026, before the open |
| Status | Confirmed · 14:37 ET, Nov 12 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. Twist Bioscience’s fiscal year ends in September, so the quarter ended Sep 30, 2026 is its Q4 fiscal 2026.
Twist Bioscience EPS surprise history: last 5 quarters
Twist Bioscience beat the EPS estimate in 2 of its last 5 reports, with an average surprise of -31.9%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Nov 12, 2026 | -$0.20 | -$0.32 | -60.0% | Miss | – |
| Aug 3, 2026 | -$0.28 | -$0.56 | -100.0% | Miss | +8.6% |
| May 4, 2026 | -$0.53 | -$0.60 | -13.2% | Miss | -6.1% |
| Feb 2, 2026 | -$0.52 | -$0.50 | +3.8% | Beat | +12.8% |
| Nov 14, 2025 | -$0.50 | -$0.45 | +10.0% | Beat | -11.5% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
TWST stock reaction to the report
TWST moved -6.83% in the first session that reflects the report (close of Nov 11, 2026 $122.59 to close of Nov 12, 2026 $114.22).
Next TWST earnings report
Twist Bioscience has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the TWST earnings calendar.
ATLAS fair value and signal for TWST
| Last price | $110.13 (-3.6%) |
|---|---|
| Chance of a higher close in 1 month | 43% (normal range $85.33–$128.08) |
These are model outputs from the same valuation and calibrated model as the Twist Bioscience stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Twist Bioscience Q4 fiscal 2026 earnings: frequently asked questions
Did Twist Bioscience beat earnings estimates for Q4 fiscal 2026?
Twist Bioscience reported EPS of -$0.32 against an analyst estimate of -$0.20: a miss of $0.12 (60.0%).
When did Twist Bioscience report Q4 fiscal 2026 results?
Twist Bioscience reported on Thursday, November 12, 2026, before the open, for the quarter ended Wednesday, September 30, 2026.
How often does TWST beat EPS estimates?
In its last 5 reports with a recorded result, Twist Bioscience beat the EPS estimate 2 times; the average surprise was -31.9%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer